Literature DB >> 12435303

[Is mucinous colorectal adenocarcinoma a distinct entity?].

R Adell1, E Marcote, M A Segarra, V Pellicer, R Gamón, A M Bayón, M Canales, A Torner.   

Abstract

INTRODUCTION: Several publications have demonstrated that mucinous carcinomas of the colon and rectum are associated with certain clinicopathological and genetic peculiarities that distinguish them from non-mucinous carcinomas. The principal aim of this study was to evaluate whether the biological behavior of mucinous carcinomas differs from that of intestinal carcinomas in patients undergoing surgery for colorectal cancer. PATIENTS: Between January 1993 and December 2000, 215 patients. underwent surgery in our hospital for colorectal cancer. The patients were divided into two groups according to histological type: tumors were intestinal in 169 patients (82%) and mucinous in 36 (17.6%). Patients undergoing non-resective surgery and those with tumors of other histological types (n = 10) were excluded.
RESULTS: The percentage of patients aged less than 50 years in the group with mucinous carcinoma was 19% (7/36) compared with 4% (7/169) in the non-mucinous group (p = 0.001). Regarding presenting symptoms, anemia was more frequent in patients with mucinous carcinoma (18.2% [n = 6] vs 5.7% [n = 8]) and a change in bowel habits was less frequent (15% [n = 5] vs 34.3% [n = 48]; p < 0.05). A total of 63.9% of mucinous carcinomas (n = 23) were located in the proximal colon (cecum, ascending and transverse colon) compared with 21.3% (n = 36) of non-mucinous carcinomas (p < 0.001). Surgical intention was palliative in 41.7% (n = 23.7) of mucinous carcinomas and in 23.7% (n = 40) of non-mucinous carcinomas (p < 0.05). The mean tumoral size was 6.2 2.5 cm in mucinous carcinomas and 4.7 2 in non-mucinous carcinomas (p = 0.001). Patients with mucinous carcinoma presented a higher percentage of nodal and distant metastases and a lower percentage of early stage tumors (p < 0.05). However, no differences were found in survival between the two histological types.
CONCLUSION: Mucinous tumors were more frequently located in the right colon and in patients less than 50 years old and were more likely to be in more advanced stages than non-mucinous tumors but no differences were found in survival according to tumor type.

Entities:  

Mesh:

Year:  2002        PMID: 12435303

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  5 in total

1.  Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers.

Authors:  Min-Hoe Chew; Shen-Ann Eugene Yeo; Zhi-Peng Ng; Kiat-Hon Lim; Poh-Koon Koh; Kheng-Hong Ng; Kong-Weng Eu
Journal:  Int J Colorectal Dis       Date:  2010-08-05       Impact factor: 2.571

2.  The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.

Authors:  Brunella Barbaro; Lucia Leccisotti; Fabio M Vecchio; Marialuisa Di Matteo; Teresa Serra; Marco Salsano; Andrea Poscia; Claudio Coco; Roberto Persiani; Sergio Alfieri; Maria Antonietta Gambacorta; Vincenzo Valentini; Alessandro Giordano; Lorenzo Bonomo
Journal:  Br J Radiol       Date:  2016-11-15       Impact factor: 3.039

3.  Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis.

Authors:  Rodrigo Oliva Perez; Bárbara Helou Bresciani; Cláudio Bresciani; Igor Proscurshim; Desiderio Kiss; Joaquim Gama-Rodrigues; Diego Daniel Pereira; Viviane Rawet; Ivan Cecconnello; Angelita Habr-Gama
Journal:  Int J Colorectal Dis       Date:  2008-05-06       Impact factor: 2.571

4.  Effect of mucin production on survival in colorectal cancer: a case-control study.

Authors:  Mirna H Farhat; Kassem A Barada; Ayman N Tawil; Doha M Itani; Hassan A Hatoum; Ali I Shamseddine
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

5.  Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?

Authors:  Vijai Simha; Rakesh Kapoor; Rajesh Gupta; Amit Bahl; Ritambhara Nada
Journal:  J Gastrointest Oncol       Date:  2014-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.